A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Replimune Group, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 37,287 shares of REPL stock, worth $465,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,287
Previous 24,405 52.78%
Holding current value
$465,714
Previous $219,000 86.3%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.09 - $11.23 $104,215 - $144,664
12,882 Added 52.78%
37,287 $408,000
Q2 2024

Aug 14, 2024

BUY
$5.01 - $9.46 $122,269 - $230,871
24,405 New
24,405 $219,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $616M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.